On Tuesday, Atyr Pharma Inc (NASDAQ: ATYR) was 5.45% up from the session before settling in for the closing price of $3.12. A 52-week range for ATYR has been $1.14 – $3.80.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 436.18% over the past five years. When this article was written, the company’s average yearly earnings per share was at 2.79%. With a float of $81.75 million, this company’s outstanding shares have now reached $83.94 million.
Let’s look at the performance matrix of the company that is accounted for 59 employees. In terms of profitability, gross margin is -563.83%, operating margin of -28958.72%, and the pretax margin is -27155.32%.
Atyr Pharma Inc (ATYR) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Atyr Pharma Inc stocks. The insider ownership of Atyr Pharma Inc is 2.61%, while institutional ownership is 63.01%. The most recent insider transaction that took place on Jul 24 ’24, was worth 101,038. In this transaction Director of this company bought 52,300 shares at a rate of $1.93, taking the stock ownership to the 413,023 shares. Before that another transaction happened on Jul 22 ’24, when Company’s Director bought 41,052 for $1.74, making the entire transaction worth $71,500. This insider now owns 354,075 shares in total.
Atyr Pharma Inc (ATYR) Latest Financial update
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted -0.25 earnings per share (EPS) during the time that was less than consensus figure (set at -0.24) by -0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.25 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 2.79% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 13.00% during the next five years compared to 43.36% growth over the previous five years of trading.
Atyr Pharma Inc (NASDAQ: ATYR) Trading Performance Indicators
You can see what Atyr Pharma Inc (ATYR) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 5.41. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1200.74.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.94, a number that is poised to hit -0.23 in the next quarter and is forecasted to reach -0.80 in one year’s time.
Technical Analysis of Atyr Pharma Inc (ATYR)
Atyr Pharma Inc (NASDAQ: ATYR) saw its 5-day average volume 0.94 million, a positive change from its year-to-date volume of 0.58 million. As of the previous 9 days, the stock’s Stochastic %D was 40.70%. Additionally, its Average True Range was 0.24.
During the past 100 days, Atyr Pharma Inc’s (ATYR) raw stochastic average was set at 77.73%, which indicates a significant increase from 48.48% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 77.43% in the past 14 days, which was higher than the 73.54% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.65, while its 200-day Moving Average is $2.01. Nevertheless, the first resistance level for the watch stands at $3.42 in the near term. At $3.55, the stock is likely to face the second major resistance level. The third major resistance level sits at $3.74. If the price goes on to break the first support level at $3.11, it is likely to go to the next support level at $2.92. The third support level lies at $2.79 if the price breaches the second support level.
Atyr Pharma Inc (NASDAQ: ATYR) Key Stats
There are 83,942K outstanding shares of the company, which has a market capitalization of 276.17 million. As of now, sales total 350 K while income totals -50,390 K. Its latest quarter income was 0 K while its last quarter net income were -16,310 K.
